News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,443 Results
Type
Article (40950)
Company Profile (267)
Press Release (681216)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204683)
Career Advice (2025)
Deals (35535)
Drug Delivery (112)
Drug Development (81393)
Employer Resources (173)
FDA (16419)
Job Trends (14947)
News (346426)
Policy (32733)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (34)
Adcomms (24)
Allergies (146)
Alliances (49577)
ALS (172)
Alzheimer's disease (1677)
Antibody-drug conjugate (ADC) (316)
Approvals (16691)
Artificial intelligence (522)
Autoimmune disease (160)
Automation (43)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (193)
Biotechnology (174)
Bladder cancer (160)
Brain cancer (57)
Breast cancer (646)
Cancer (4872)
Cardiovascular disease (407)
Career advice (1710)
Career pathing (36)
CAR-T (284)
CDC (47)
Celiac Disease (2)
Cell therapy (750)
Cervical cancer (37)
Clinical research (69635)
Collaboration (1722)
Company closure (4)
Compensation (1179)
Complete response letters (57)
COVID-19 (2715)
CRISPR (93)
C-suite (866)
Cystic fibrosis (143)
Data (6323)
Decentralized trials (2)
Denatured (25)
Depression (135)
Diabetes (504)
Diagnostics (6712)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (256)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90280)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (117488)
Executive appointments (985)
FDA (19583)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1482)
Gene editing (200)
Generative AI (44)
Gene therapy (600)
GLP-1 (968)
Government (4668)
Grass and pollen (6)
Guidances (384)
Healthcare (18883)
HIV (62)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (254)
Immuno-oncology (62)
Indications (121)
Infectious disease (2993)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (255)
Interviews (316)
IPO (16643)
IRA (50)
Job creations (3643)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7951)
Liver cancer (91)
Longevity (15)
Lung cancer (660)
Lymphoma (382)
Machine learning (42)
Management (59)
Manufacturing (811)
MASH (165)
Medical device (13780)
Medtech (13838)
Mergers & acquisitions (19970)
Metabolic disorders (1277)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (323)
Neuropsychiatric disorders (89)
Neuroscience (2931)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4515)
Now hiring (68)
Obesity (599)
Opinion (265)
Ovarian cancer (167)
Pain (201)
Pancreatic cancer (232)
Parkinson's disease (285)
Partnered (33)
Patents (510)
Patient recruitment (498)
Peanut (58)
People (58935)
Pharmaceutical (62)
Pharmacy benefit managers (30)
Phase 1 (21708)
Phase 2 (30648)
Phase 3 (22831)
Pipeline (5505)
Policy (290)
Postmarket research (2564)
Preclinical (9203)
Press Release (64)
Prostate cancer (240)
Psychedelics (48)
Radiopharmaceuticals (284)
Rare diseases (854)
Real estate (5955)
Recruiting (70)
Regulatory (24571)
Reports (53)
Research institute (2391)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (150)
Series A (240)
Series B (191)
Service/supplier (11)
Sickle cell disease (98)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1013)
Venture capital (89)
Weight loss (383)
Women's health (96)
Worklife (18)
Date
Today (154)
Last 7 days (698)
Last 30 days (2390)
Last 365 days (29892)
2026 (4167)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29266)
2010 (27328)
Location
Africa (737)
Alabama (85)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (39247)
Australia (6417)
California (11443)
Canada (3322)
China (1106)
Colorado (482)
Connecticut (484)
Delaware (341)
Europe (84629)
Florida (1720)
Georgia (363)
Hawaii (3)
Idaho (61)
Illinois (874)
India (70)
Indiana (529)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1400)
Massachusetts (8187)
Michigan (328)
Minnesota (631)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (124)
New Hampshire (79)
New Jersey (3039)
New Mexico (28)
New York (3009)
North Carolina (1470)
North Dakota (8)
Northern California (5603)
Ohio (338)
Oklahoma (21)
Oregon (41)
Pennsylvania (2307)
Puerto Rico (24)
Rhode Island (48)
South America (1109)
South Carolina (68)
South Dakota (1)
Southern California (4461)
Tennessee (177)
Texas (1757)
United States (40537)
Utah (342)
Vermont (1)
Virginia (265)
Washington D.C. (81)
Washington State (930)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,443 Results for "medicinova inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
January 30, 2026
·
7 min read
Press Releases
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
December 18, 2025
·
5 min read
Press Releases
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
November 18, 2025
·
5 min read
Press Releases
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
October 31, 2025
·
5 min read
Press Releases
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
November 6, 2025
·
5 min read
Press Releases
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
October 7, 2025
·
4 min read
Press Releases
MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
November 5, 2025
·
6 min read
Press Releases
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
August 26, 2025
·
5 min read
Press Releases
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
December 8, 2025
·
6 min read
Press Releases
MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025
·
4 min read
1 of 72,245
Next
